Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01788696 · ClinicalTrials.gov registry record · Phase 1

Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects

A Phase 1 study, sponsored by Duke University.

Completed
Registry status
Phase 1
Development phase
20
Enrollment target

NCT01788696: Completed Phase 1 study, sponsored by Duke University.

NCT01788696 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01788696, a Phase 1 study, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 1
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the impact of imaging the brain as a diagnostic tool in the management of early Parkinson's disease (PD).

Primary Outcome

Patient and treating physician agree on a treatment plan at visit 3. Patient adherence to medications will be evaluated based on pill count at each follow-up study visit. Additionally, each patient will record their adherence to therapy on the Patient Expectations and Disease-related Questionnaire (PEDQ) at each follow-up study visit, allowing the study team to track compliance with pharmacologic therapy as well as treatments including therapy exercise plans.

Interventions

  • RADIATION Group A - Early Imaging
  • RADIATION Group B - Delayed Imaging

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-06
Est. Completion 2015-06
Phase Phase 1
Duke University

1,725 total trials

What the finished NCT01788696 record still lists

NCT01788696 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 2 interventions - of which Group A - Early Imaging is the first listed.

NCT01788696 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01788696 about?

NCT01788696 is a clinical study titled "Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects". The purpose of this study is to evaluate the impact of imaging the brain as a diagnostic tool in the management of early Parkinson's disease (PD).

What is the current status of trial NCT01788696?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2012-06. Estimated completion is 2015-06.

What interventions are being tested in trial NCT01788696?

The interventions under investigation include: Group A - Early Imaging (RADIATION), Group B - Delayed Imaging (RADIATION).

Who is sponsoring clinical trial NCT01788696?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01788696's enrollment target sits among peer trials

20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01788696, the US trial registry maintained by the National Library of Medicine. NCT01788696 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.